ASX
Paradigm Biopharmaceuticals
PAR:ASX•Healthcare
Sensitive ASX Announcement
Published Canine Study Strengthens iPPS Phase 3 Rationale
Published: 11/02/26, 09:43am (AEST)•5 pages